Skip to main content
Caplight Logo









Spica Therapeutics

Spica Therapeutics

Private
AntwerpHealthcare & Life Scienceshttps://spicatx.com/

Last Round

Grant

Aug 27, 2025

Total Funding Raised

$12.54M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Spica Therapeutics is a biotechnology company that develops macrophage-subset targeted therapies using a proprietary functional fingerprinting platform to address oncology and fibroinflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverymacrophage therapyoncologyprecision medicinefibroinflammatory diseaseautoimmune diseaseantibody developmenttargeted therapybiotech startuppreclinical researchdrug pipelinetherapeuticsbiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spica Therapeutics Comparables

Compare Spica Therapeutics with similar companies based on industry and business-model similarity.

Spica Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Macomics
87%
DEM BioPharma
79%
Resolute Science
79%

Spica Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 27, 2025
SeedJun 4, 2025

Spica Therapeutics Investors

Notable investors and investment history

Spica Therapeutics investors
InvestorRounds
VLAIOGrant
Bioqube VenturesSeed
PMVSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 47% MoM.

  • Aug 27, 2025

    $1.2M grant received

Spica Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Spica Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Spica Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAntwerp
Employee Range16
Year Founded2024
Last FundingAug 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?